DE2160009A1 - Verfahren und Vorrichtung zur Herstellung eines injizierbaren Trägers für Radioisotope - Google Patents
Verfahren und Vorrichtung zur Herstellung eines injizierbaren Trägers für RadioisotopeInfo
- Publication number
- DE2160009A1 DE2160009A1 DE19712160009 DE2160009A DE2160009A1 DE 2160009 A1 DE2160009 A1 DE 2160009A1 DE 19712160009 DE19712160009 DE 19712160009 DE 2160009 A DE2160009 A DE 2160009A DE 2160009 A1 DE2160009 A1 DE 2160009A1
- Authority
- DE
- Germany
- Prior art keywords
- sterile
- solution
- gelatin
- freeze
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title description 8
- 239000000243 solution Substances 0.000 claims description 70
- 229920000159 gelatin Polymers 0.000 claims description 37
- 235000019322 gelatine Nutrition 0.000 claims description 37
- 108010010803 Gelatin Proteins 0.000 claims description 28
- 239000008273 gelatin Substances 0.000 claims description 28
- 235000011852 gelatine desserts Nutrition 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 claims description 20
- 235000019345 sodium thiosulphate Nutrition 0.000 claims description 20
- 239000002253 acid Substances 0.000 claims description 18
- 239000004133 Sodium thiosulphate Substances 0.000 claims description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 239000011363 dried mixture Substances 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 10
- 239000001828 Gelatine Substances 0.000 claims description 9
- 239000000872 buffer Substances 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 7
- PODWXQQNRWNDGD-UHFFFAOYSA-L sodium thiosulfate pentahydrate Chemical compound O.O.O.O.O.[Na+].[Na+].[O-]S([S-])(=O)=O PODWXQQNRWNDGD-UHFFFAOYSA-L 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 5
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 claims description 4
- 239000003708 ampul Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000008363 phosphate buffer Substances 0.000 claims 1
- BBMHARZCALWXSL-UHFFFAOYSA-M sodium dihydrogenphosphate monohydrate Chemical compound O.[Na+].OP(O)([O-])=O BBMHARZCALWXSL-UHFFFAOYSA-M 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 10
- 238000002347 injection Methods 0.000 description 9
- 239000007924 injection Substances 0.000 description 9
- 239000002245 particle Substances 0.000 description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 241001631457 Cannula Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical compound [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 239000000084 colloidal system Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 235000014413 iron hydroxide Nutrition 0.000 description 3
- NCNCGGDMXMBVIA-UHFFFAOYSA-L iron(ii) hydroxide Chemical compound [OH-].[OH-].[Fe+2] NCNCGGDMXMBVIA-UHFFFAOYSA-L 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 3
- 235000019799 monosodium phosphate Nutrition 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- APFVFJFRJDLVQX-YPZZEJLDSA-N indium-113 Chemical compound [113In] APFVFJFRJDLVQX-YPZZEJLDSA-N 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Inorganic materials [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OUBOUGQGSVYGNK-UHFFFAOYSA-J S(=S)(=O)([O-])[O-].[Fe+3].[Na+].S(=S)(=O)([O-])[O-] Chemical compound S(=S)(=O)([O-])[O-].[Fe+3].[Na+].S(=S)(=O)([O-])[O-] OUBOUGQGSVYGNK-UHFFFAOYSA-J 0.000 description 1
- GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000012928 buffer substance Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- FGRVOLIFQGXPCT-UHFFFAOYSA-L dipotassium;dioxido-oxo-sulfanylidene-$l^{6}-sulfane Chemical compound [K+].[K+].[O-]S([O-])(=O)=S FGRVOLIFQGXPCT-UHFFFAOYSA-L 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- MSNWSDPPULHLDL-UHFFFAOYSA-K ferric hydroxide Chemical compound [OH-].[OH-].[OH-].[Fe+3] MSNWSDPPULHLDL-UHFFFAOYSA-K 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 150000004686 pentahydrates Chemical class 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 150000004764 thiosulfuric acid derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9527170A | 1970-12-04 | 1970-12-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2160009A1 true DE2160009A1 (de) | 1972-06-29 |
Family
ID=22251071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19712160009 Pending DE2160009A1 (de) | 1970-12-04 | 1971-12-03 | Verfahren und Vorrichtung zur Herstellung eines injizierbaren Trägers für Radioisotope |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US3743714A (enExample) |
| DE (1) | DE2160009A1 (enExample) |
| FR (1) | FR2116420B1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2828941A1 (de) * | 1978-06-30 | 1980-01-10 | Robert Thomas Gordon | Mittel zur behandlung von krebs |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1105815A (en) * | 1977-06-17 | 1981-07-28 | Paul-Emile Bonneau | Red blood cell labelling kit |
| US4540410A (en) * | 1982-11-16 | 1985-09-10 | Serono Pharmaceutical Partners | Lyophilized compositions, preparation and use thereof |
| US5326532A (en) * | 1993-02-25 | 1994-07-05 | E. I. Du Pont De Nemours And Company | Apparatus for chemically processing toxic materials |
| US6225611B1 (en) | 1999-11-15 | 2001-05-01 | Hull Corporation | Microwave lyophilizer having corona discharge control |
| EP1870649A1 (en) * | 2006-06-20 | 2007-12-26 | Octapharma AG | Lyophilisation targetting defined residual moisture by limited desorption energy levels |
| EP3571281A4 (en) | 2017-01-27 | 2020-12-23 | Food & Beverage Innovations, LLC | DEVICE AND PROCESSES FOR PREPARATION OF GELATIN-BASED PRODUCTS |
-
1970
- 1970-12-04 US US00095271A patent/US3743714A/en not_active Expired - Lifetime
-
1971
- 1971-11-30 FR FR717142807A patent/FR2116420B1/fr not_active Expired
- 1971-12-03 DE DE19712160009 patent/DE2160009A1/de active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2828941A1 (de) * | 1978-06-30 | 1980-01-10 | Robert Thomas Gordon | Mittel zur behandlung von krebs |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2116420A1 (enExample) | 1972-07-13 |
| FR2116420B1 (enExample) | 1974-07-19 |
| US3743714A (en) | 1973-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69010221T2 (de) | In situ gebildete Polysaccharidgele. | |
| EP0108253B1 (de) | Technetium-99m-Tetraphosphonate zur szintigraphischen Darstellung RES-haltiger Organe und der Lymphgefässe und Verfahren zu deren Herstellung | |
| DE2358759A1 (de) | Verfahren zur herstellung einer therapeutischen zusammensetzung | |
| CH659394A5 (de) | Behaelter enthaltend ein schwerloesliches lyophilisiertes arzneimittel auf protein-basis. | |
| DE2160009A1 (de) | Verfahren und Vorrichtung zur Herstellung eines injizierbaren Trägers für Radioisotope | |
| DE2534985C2 (enExample) | ||
| DE1951769A1 (de) | Pharmazeutische Suspension und Stabilisierungsverfahren | |
| DE2710728C2 (de) | Reagens für die radiologische Abtastung von Organen, Verfahren zu seiner Herstellung und seine Verwendung | |
| DE2115066A1 (de) | Verpackungseinheit fur radioaktive Kennzeichnungsmittel | |
| EP0363502B1 (de) | Flüssiges, wismuthaltiges Arzneipräparat, Verfahren zum Herstellen desselben und seine Verwendung | |
| AT395533B (de) | Verfahren zur herstellung einer pharmazeutischen, parenteralen dosiseinheit von na-piperacillin | |
| DE68902755T2 (de) | Antineoplastische formulierungen. | |
| EP0003041B1 (de) | Technetium-99m-markiertes Diagnostikum zur Darstellung des retikuloendothelialen Systems (RES) und Verfahren zu seiner Herstellung | |
| DE3879966T2 (de) | Kalziumchlorid enthaltende zubereitung bei der vorbeugung und behandlung von hypocalcaemie bei wiederkaeuern. | |
| DE2327870C2 (de) | Verfahren zur Herstellung eines mit 99↑m↑ Tc markierten Phosphat-Zinn-Komplexes zur Szintigraphie | |
| DE2013039A1 (de) | Arzneimitteltablette zur oralen Verabreichung | |
| DE2950832C2 (de) | Spritzfertige injizierbare wäßrige Lösungen der Alkalisalze von Canrenoinsäure und Furosemid | |
| DE2124751A1 (de) | Verfahren zur Herstellung eines diagnostischen Präparats auf Basis eines mit 99mTc markierten Eisenkomplexes | |
| AT222276B (de) | Verfahren zur Herstellung einer injizierbaren Lösung von Acetylsalicylsäure | |
| DE2304381C3 (de) | Hoch 113m Indium-acetylacetonat enthaltendes Mittel für die szintigraphische Funktionsdiagnostik der Leber auf dessen Herstellung | |
| DE2556001C3 (de) | Spritzfertige injizierbare Lösungen mit einem Gehalt an Alkalicanrenoat | |
| DE3530821C2 (de) | Luprostiolhaltige Lösung | |
| DE2606561C3 (de) | Verfahren zur Herstellung eines Technetium-99m-markierten Knochendiagnostikums | |
| DE2536008C3 (de) | Verfahren zur Herstellung von zur Bindung von Technetium geeigneten zinnhaltigen Humanserumalbumin-Partikeln | |
| DE2433643A1 (de) | Zweikammerbehaelter fuer pharmazeutische loesungen |